U.S. Authorizes Pfizer/BioNTech COVID Vaccine for Children 12 to 15

U.S. regulators on Monday authorized Pfizer and BioNTech's COVID-19 vaccine for use in children as young as 12, widening the country's inoculation program as vaccination rates have slowed significantly.